Robbins LLP Urges Neogen Stockholders with Losses to Attend Class Action Notice

Attention Neogen Shareholders

Robbins LLP, a leading firm in shareholder rights litigation, is reaching out to investors of Neogen Corporation (NASDAQ: NEOG) who have faced considerable financial losses. A class action lawsuit has been initiated on behalf of those who purchased or acquired Neogen securities between January 6, 2023, and June 3, 2025. It is crucial for affected stockholders to contact Robbins LLP promptly to discuss their rights before the lead plaintiff deadline.

Background of the Situation

Neogen Corporation specializes in food safety and offers a variety of products and services aimed at ensuring food and animal safety. However, the company has recently faced significant challenges, leading to severe financial repercussions for its investors.

The lawsuit alleges that during the specified class period, Neogen misled its shareholders regarding the integration process with 3M Company. The plaintiff claims that the company made a series of false representations about the ongoing integration that created a false sense of security among investors. In reality, significant issues plagued the integration process, and these problems were not adequately disclosed to shareholders.

The Allegations

On January 10, 2025, Neogen revealed troubling financial information, including a net income that was significantly negative, mainly due to a $461 million non-cash goodwill impairment charge associated with the 3M acquisition. In addition, the company revised its fiscal year 2025 revenue and EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) guidance downward, indicating serious financial distress. Following this announcement, Neogen's stock price dropped by 5%, closing at $12.36 per share.

Furthermore, on April 9, 2025, the company reported a quarterly revenue decline of 3.4% attributed partly to ongoing integration troubles. They once again reduced their revenue and EBITDA outlook for FY25 and announced that their CEO would be stepping down. As a result, Neogen’s share price plummeted by 28% on that news.

The situation worsened on June 4, 2025, when Neogen announced that it expected its EBITDA margin to be around the high-teens, a significant drop from a profit margin of 22% in the previous quarter. Following this announcement, the stock dropped an additional 17%, closing at $4.96 per share. Overall, from the peak stock price of $23.84 on August 15, 2023, to the recent close, Neogen's stock has plummeted by $18.88, representing an astounding 79% decrease and erasing over $4 billion from the company’s market capitalization.

What’s Next?

Affected shareholders are encouraged to reach out to Robbins LLP to explore their eligibility to join the class action lawsuit. Interested parties might wish to assume the role of lead plaintiff, which entails guiding the litigation on behalf of other class members. Participation is optional, and it is crucial to understand that you can remain an absent member of the class should you choose not to take any action.

Robbins LLP operates on a contingency fee basis, meaning that shareholders will not incur any fees unless they recover losses through the lawsuit. This setup ensures that victims of the alleged incorrect representations will have the opportunity to seek justice without upfront costs.

About Robbins LLP

Since 2002, Robbins LLP has been a pivotal player in protecting shareholder rights. The dedicated team focuses on helping investors recover losses, improve governance practices, and hold executives accountable for their actions.

For shareholders looking to receive updates or notifications about the class action, including any settlements, consider signing up for Stock Watch today. Being informed is essential, especially during such turbulent times.